MAPT and Alzheimer disease: The aim of this study was to characterize and compare the binding properties of 3H-MK6240 in human post-mortem brain tissue from AD cases with its properties in nondemented control tissue and with the properties of the first-generation tau tracers in a head-to-head comparison study.